A new Government Accountability Office analysis suggests that pharmaceutical companies benefit handsomely from advertising brand-name drugs on television and in other media. People look at the loving...
Diane Archer
Health care coverage denied? Appeal, it’s easy
In its infinite wisdom, Congress is eyeing a fix for people with poor health insurance whose health care is wrongly denied or delayed. No, it’s not guaranteeing everyone good health insurance...
Medicare stops covering costly brain-cancer drug
Kate Gibson reports for CBS Money Watch that Medicare is no longer covering a costly brain-cancer drug because the company that manufactures it charges way too much for it. The drug’s...
For-profit hospitals are causing rising medical debt and...
Axios reports new findings, in partnership with Johns Hopkins, that medical debt continues to rise. Rising medical debt should come as no surprise as insurers shift more costs onto patients through...
ER coverage: Private health insurers control our coverage
If you think you like your private health insurance, watch out. Private health insurers control the terms of your coverage. What they cover today can be very different tomorrow. Do not count on...
States lack power to take on health insurers and guarantee...
So far, President Biden has done little to move forward with health insurance reform at the federal level; most states lack the will and the skill to take on the health insurance industry and...
Better health comes with beneficial microbes and coffee
Anahad O writes for the New York Times on a new study published in Nature Magazine that confirms much of what we know about the link between good nutrition and better health. In short, our guts are...
Retail prices for brand name drugs rise at more than twice rate...
Leigh Purvis and Dr. Stephen W. Schondelmeyer’s 2021 Rx Price Watch report finds that retail price increases for brand-name drugs have been rising year-over-year at more than twice the rate of...
Will Congressional Democrats agree on a way to lower drug prices?
The Wall Street Journal reports that Congressional Democrats are trying to find a path to lowering drug prices. But, will they agree on a policy that delivers lower drug prices? Or, will they defer...
New Alzheimer’s drug has questionable benefits and costs a...
In the “not so surprising” department, Axios reports that the FDA has just approved a new drug to treat Alzheimer’s disease that has questionable benefits and costs a small fortune...